SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SkinHealth Systems Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
SkinHealth Systems Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $207.75M | $209.72M | $212.71M | $211.73M | $213.08M | $212.64M | $208.89M | $204.37M | $199.55M | $196.06M | $191.36M | $186.61M | 71.6% | -2.5% |
| Delivery Systems | $82.30M | $86.40M | $88.08M | $90.19M | $96.98M | $109.84M | $125.40M | $143.25M | $166.68M | $197.06M | $206.63M | $212.70M | 28.4% | -15.1% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $200.17M | $202.33M | $203.98M | $203.63M | $207.24M | $212.92M | $216.99M | – | – | – | – | – | 69.0% | -3.4% |
| Europe, the Middle East and Africa | $63.54M | $67.04M | $68.30M | $66.67M | $66.71M | $67.52M | $71.63M | $73.20M | $78.16M | $87.51M | $88.09M | $86.63M | 21.9% | -4.7% |
| Asia-Pacific | $26.33M | $26.75M | $28.52M | $31.62M | $36.11M | $42.03M | $45.67M | $55.10M | $68.93M | $80.55M | $82.19M | $79.43M | 9.1% | -27.1% |
| United States | – | – | – | – | – | – | – | $219.32M | $219.14M | $225.06M | $227.71M | $233.24M | – | – |
From the segment and revenue-disaggregation notes of SkinHealth Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.